Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing antivector immunity in cancer patients

E Brouwer; MJ Havenga; O Ophorst; B Leeuw; L Gijsbers; G Gillissen; RC Hoeben; Maarten Horst; D Nanda; Clemens Dirven; CJJ Avezaat; J Goudsmit; Peter Sillevis Smitt

doi:10.1038/sj.cgt.7701010

Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing antivector immunity in cancer patients

E Brouwer, MJ Havenga, O Ophorst, B Leeuw, L Gijsbers, G Gillissen, RC Hoeben, Maarten Horst, D Nanda, Clemens Dirven, CJJ Avezaat, J Goudsmit, Peter Sillevis Smitt

Research output: Contribution to journal › Article › Academic › peer-review

41 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	211-219
Number of pages	9
Journal	Cancer Gene Therapy
Volume	14
Issue number	2
DOIs	https://doi.org/10.1038/sj.cgt.7701010
Publication status	Published - 2007

Research programs

EMC MM-03-44-06
EMC OR-01-45-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/sj.cgt.7701010

http://hdl.handle.net/1765/36516

Cite this

Brouwer, E., Havenga, MJ., Ophorst, O., Leeuw, B., Gijsbers, L., Gillissen, G., Hoeben, RC., Horst, M., Nanda, D., Dirven, C., Avezaat, CJJ., Goudsmit, J., & Sillevis Smitt, P. (2007). Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing antivector immunity in cancer patients. Cancer Gene Therapy, 14(2), 211-219. https://doi.org/10.1038/sj.cgt.7701010

@article{6e474a55a4754c6aae8bd7b1a208d495,

title = "Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing antivector immunity in cancer patients",

author = "E Brouwer and MJ Havenga and O Ophorst and B Leeuw and L Gijsbers and G Gillissen and RC Hoeben and Maarten Horst and D Nanda and Clemens Dirven and CJJ Avezaat and J Goudsmit and {Sillevis Smitt}, Peter",

year = "2007",

doi = "10.1038/sj.cgt.7701010",

language = "Undefined/Unknown",

volume = "14",

pages = "211--219",

journal = "Cancer Gene Therapy",

issn = "0929-1903",

publisher = "Springer Nature",

number = "2",

}

Brouwer, E, Havenga, MJ, Ophorst, O, Leeuw, B, Gijsbers, L, Gillissen, G, Hoeben, RC, Horst, M, Nanda, D, Dirven, C, Avezaat, CJJ, Goudsmit, J & Sillevis Smitt, P 2007, 'Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing antivector immunity in cancer patients', Cancer Gene Therapy, vol. 14, no. 2, pp. 211-219. https://doi.org/10.1038/sj.cgt.7701010

TY - JOUR

T1 - Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing antivector immunity in cancer patients

AU - Brouwer, E

AU - Havenga, MJ

AU - Ophorst, O

AU - Leeuw, B

AU - Gijsbers, L

AU - Gillissen, G

AU - Hoeben, RC

AU - Horst, Maarten

AU - Nanda, D

AU - Dirven, Clemens

AU - Avezaat, CJJ

AU - Goudsmit, J

AU - Sillevis Smitt, Peter

PY - 2007

Y1 - 2007

U2 - 10.1038/sj.cgt.7701010

DO - 10.1038/sj.cgt.7701010

M3 - Article

C2 - 17082793

SN - 0929-1903

VL - 14

SP - 211

EP - 219

JO - Cancer Gene Therapy

JF - Cancer Gene Therapy

IS - 2

ER -